GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,483,403 | +3.2% | 1,282,289 | +1.5% | 7.25% | +9.8% |
| Q2 2023 | $45,029,371 | -0.9% | 1,263,458 | -1.1% | 6.60% | +0.9% |
| Q1 2023 | $45,453,031 | +5.4% | 1,277,476 | +4.1% | 6.54% | +15.3% |
| Q4 2022 | $43,113,031 | -99.9% | 1,226,906 | -6.0% | 5.68% | -5.1% |
| Q3 2022 | $38,404,190,000 | -38.4% | 1,304,939 | -8.8% | 5.98% | -28.7% |
| Q2 2022 | $62,297,972,000 | +0.2% | 1,431,160 | +0.3% | 8.39% | +6.3% |
| Q1 2022 | $62,145,788,000 | -2.0% | 1,426,664 | -0.8% | 7.89% | -9.4% |
| Q4 2021 | $63,440,893,000 | +22.7% | 1,438,569 | +6.3% | 8.71% | +19.7% |
| Q3 2021 | $51,711,809,000 | +0.1% | 1,353,358 | +4.3% | 7.28% | -1.6% |
| Q2 2021 | $51,650,880,000 | +14.3% | 1,297,109 | +2.5% | 7.40% | +5.8% |
| Q1 2021 | $45,175,331,000 | -4.2% | 1,265,770 | -1.3% | 6.99% | -15.0% |
| Q4 2020 | $47,174,803,000 | -10.9% | 1,281,924 | -8.9% | 8.23% | -18.0% |
| Q3 2020 | $52,947,774,000 | -14.9% | 1,406,689 | -7.3% | 10.04% | -4.5% |
| Q2 2020 | $62,201,405,000 | +6.3% | 1,517,918 | -1.7% | 10.51% | -1.7% |
| Q1 2020 | $58,487,686,000 | -21.6% | 1,543,618 | -2.8% | 10.70% | +18.3% |
| Q4 2019 | $74,603,639,000 | +7.9% | 1,587,628 | -2.0% | 9.05% | +4.3% |
| Q3 2019 | $69,167,165,000 | +7.7% | 1,620,599 | +1.0% | 8.67% | +8.0% |
| Q2 2019 | $64,232,661,000 | +20.4% | 1,605,014 | +25.7% | 8.03% | -3.7% |
| Q1 2019 | $53,347,024,000 | +10.7% | 1,276,550 | +1.2% | 8.34% | -4.1% |
| Q4 2018 | $48,180,518,000 | -3.4% | 1,260,940 | +1.6% | 8.69% | +13.4% |
| Q3 2018 | $49,871,697,000 | +0.0% | 1,241,516 | +0.4% | 7.66% | -3.4% |
| Q2 2018 | $49,847,023,000 | +3.7% | 1,236,592 | +0.5% | 7.93% | +3.6% |
| Q1 2018 | $48,081,183,000 | +19.0% | 1,230,642 | +8.0% | 7.66% | +20.7% |
| Q4 2017 | $40,406,111,000 | -2.5% | 1,139,163 | +11.6% | 6.35% | +0.2% |
| Q3 2017 | $41,458,081,000 | -8.9% | 1,021,135 | -3.2% | 6.33% | -8.7% |
| Q2 2017 | $45,495,265,000 | +2.7% | 1,055,085 | +0.4% | 6.94% | -9.0% |
| Q1 2017 | $44,309,950,000 | +38.1% | 1,050,995 | +26.1% | 7.62% | +40.6% |
| Q4 2016 | $32,090,960,000 | – | 833,315 | – | 5.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |